| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09bd410b3afd879515568aa52f95a35 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-22 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-66 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0276b4885d1e01814ce96f607b1d08a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eebac6f66aa470100492b8e8c4e9ce9 |
| publicationDate |
2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018138267-A1 |
| titleOfInvention |
Method for determining the efficacy of a g-csf containing composition |
| abstract |
The present invention relates to a method for determining the efficacy of a granulocyte-colony stimulating factor (G-CSF) containing composition comprising the steps of administration of the G-CSF containing composition to a subject, measurement of the blood glucose level of said subject and determining the efficacy of the G-CSF containing composition based on the blood glucose level. |
| priorityDate |
2017-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |